https://www.selleckchem.com/products/ti17.html
Photon-counting detector (PCD) CT has emerged as a novel imaging modality that represents a fundamental shift in the way that CT systems detect X-rays. Following preclinical and clinical investigations showing benefits of PCD CT for a range of imaging tasks, the first commercial PCD CT system was approved by the U.S. FDA for clinical use in 2021. The technologic features of PCD CT are particularly well suited for musculoskeletal imaging applications. Advantages of PCD CT compared with conventional energy-integrating detector CT include sma
Gefällt mir
Kommentar
Teilen
